Target intelligence / Profile preview

Magnesium transporter MRS2 homolog, mitochondrial (MRS2)

Target
MRS2
Molecular classification
Transporter, Ion channel, CorA family homolog (structural family; related to prokaryotic CorA magnesium channels)
01

Overview

Magnesium transporter MRS2 homolog, mitochondrial (MRS2) is a pentameric, nonselective ion channel of the CorA family embedded in the inner mitochondrial membrane in mammalian cells. Unlike its prokaryotic correlates, it is regulated primarily by Ca²⁺ and exhibits permeability to Mg²⁺, Ca²⁺, Na⁺, and K⁺ ions. MRS2 plays a central role in mitochondrial magnesium homeostasis, which is essential for various mitochondrial functions including stabilization of mitochondrial DNA, RNA splicing, and ATP synthesis. Loss of MRS2 results in marked mitochondrial morphological changes, disrupted bioenergetics, and disease phenotypes associated with mitochondrial dysfunction. Its unique channel structure includes a conserved arginine ring that regulates cation movement and prevents collapse of the proton motive force vital for ATP production. Experimental inhibition of this channel is possible, but currently, no approved drugs target MRS2 directly and safety considerations are theoretical, mostly related to disruption of mitochondrial function.

Other names
MRS2HPTMRS2LMRS2-like proteinMagnesium homeostasis factorPutative magnesium transporter
02

Mechanism of action

Inhibition of Mg²⁺ transport via channel blockade (e.g., cobalt hexammine); Modulation of cation conductance through channel regulation (possible Cl⁻-mediated mechanism).

03

Biological functions

Magnesium transport across mitochondrial inner membraneMaintenance of mitochondrial magnesium homeostasisRegulation of mitochondrial integrity and ATP synthesisCation permeation (Mg²⁺, Ca²⁺, Na⁺, K⁺)Possible modulation of mitochondrial Ca²⁺ signaling and metabolic response
04

Disease associations

Neurodegenerative disease (linked to mitochondrial dysfunction)Metabolic disordersMitochondrial diseases
05

Safety considerations

Potential risk of disrupting mitochondrial function and ATP synthesis by manipulating magnesium fluxPossible impairment of mitochondrial integrity with over- or under-expressionLimited specific safety data, given lack of clinical targeting to date
06

Interacting drugs

Cobalt hexammine (experimental CorA/MRS2 inhibitor)

1 more in the full profile.

07

Biomarkers

Null (no validated biomarkers for patient selection or efficacy monitoring are reported in the current literature)

Beyond the preview

Go deeper on Magnesium transporter MRS2 homolog, mitochondrial (MRS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnesium transporter MRS2 homolog, mitochondrial (MRS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call